Polymedco, Inc.

Polymedco, Inc. Helping save lives through early detection For nearly every disease, early detection means better outcomes, lower costs, and a better experience for patients.

Polymedco partners with health care systems, payors, providers, and reference labs to build best-in-class screening and early detection solutions. Our organization has been built around a portfolio of products with exceptional performance, robust clinical evidence, and user-friendly design. Today, we offer world-leading products and customizable solutions that maximize the impact and value of our products.

Attention urgent care and free-standing ED lab professionals! Don’t miss your chance to earn P.A.C.E.® credit as you hea...
05/26/2026

Attention urgent care and free-standing ED lab professionals!

Don’t miss your chance to earn P.A.C.E.® credit as you hear Tezak share practical, tried-and-true strategies for:
• Designing point-of-care testing (POCT) programs that hold up under pressure
• Supporting moderately complex testing in high‑throughput environments
• Leveraging cardiac and acute care biomarkers for faster clinical decisions
• Building a test menu

Join us this Tuesday May 28 for the live webinar!
1:00 PM ET
“Building a High-Impact POCT Program for FSEDs and Urgent Care”

Don’t miss out! Register at: https://bit.ly/3Pp2VoO

Freestanding EDs and urgent care centers are under pressure to deliver fast, high-quality diagnostics without slowing do...
05/21/2026

Freestanding EDs and urgent care centers are under pressure to deliver fast, high-quality diagnostics without slowing down operations.

If you’re working on improving your point-of-care testing strategy, this webinar is worth your time.

Join us on May 28 at 1:00 PM ET for a live session:
“Building a High-Impact POCT Program for FSEDs and Urgent Care”

Featuring Tezak (TriCore Laboratories) sharing real-world insights on:
• Building and sustaining POCT programs
• Supporting moderately complex testing in fast-paced settings
• Using cardiac and acute care biomarkers for faster decisions
• Improving workflow and team collaboration

P.A.C.E.® credit available.
Save your spot: https://bit.ly/49aLPS9

If you’re in Point of Care, FSED, or lab leadership, this will give you practical takeaways you can apply right away.

Great to see the continued focus at DDW 2026 on improving colorectal cancer screening through approaches that are both e...
05/04/2026

Great to see the continued focus at DDW 2026 on improving colorectal cancer screening through approaches that are both evidence-based and scalable.

We have had valuable conversations with clinicians around:
• Screening adherence
• Population health strategies
• The role of FIT in expanding access

If you are attending and have not stopped by yet, we welcome you to visit Polymedco at booth 2337.

We are live at DDW 2026!Polymedco is onsite and connecting with gastroenterologists and screening leaders throughout the...
05/03/2026

We are live at DDW 2026!

Polymedco is onsite and connecting with gastroenterologists and screening leaders throughout the meeting.

If you are attending, stop by booth 2337 to:
• Connect with our team
• Discuss colorectal cancer screening strategies
• Explore how FIT supports scalable screening programs

There is also a strong lineup of poster sessions this weekend, including new research on quantitative FIT.

As DDW approaches, there will be a strong focus on new data shaping colorectal cancer screening strategies.This includes...
04/30/2026

As DDW approaches, there will be a strong focus on new data shaping colorectal cancer screening strategies.

This includes poster sessions featuring research on f***l immunochemical testing, including work on quantitative FIT and its potential future role in refining screening approaches.

If you are attending DDW 2026 in Chicago, these sessions may provide valuable perspective on how FIT continues to evolve within screening pathways.

Polymedco will be onsite and available to discuss how insights into real-world screening programs. Visit us at booth 2337.

Heading to DDW 2026?Polymedco will be onsite in Chicago from May 2–5. Our team will be available to connect and discuss ...
04/27/2026

Heading to DDW 2026?

Polymedco will be onsite in Chicago from May 2–5. Our team will be available to connect and discuss how FIT can support colorectal cancer screening programs at scale.

We are looking forward to engaging with gastroenterologists and screening leaders on topics such as:

• Improving screening adherence
• Supporting population health initiatives
• Scaling screening programs effectively

If you are attending, stop by our booth 2337 to connect.

Colorectal cancer screening continues to evolve as health systems work to improve early detection while expanding access...
04/24/2026

Colorectal cancer screening continues to evolve as health systems work to improve early detection while expanding access and adherence.

For many gastroenterologists, this means balancing clinical performance with scalable, population-based approaches.

F***l immunochemical testing remains a key part of that conversation, particularly as programs look to increase participation through noninvasive options.

Polymedco will be at DDW 2026 in Chicago from May 2 – 5 and we look forward to connecting with clinicians who are focused on advancing screening strategies.

If you are attending, we hope you will stop by our booth and connect with our team.

45 is the New 50: Why Your Colon Health Can’t WaitColorectal cancer is highly preventable, but timing is everything. If ...
04/02/2026

45 is the New 50: Why Your Colon Health Can’t Wait

Colorectal cancer is highly preventable, but timing is everything. If you are 45 or older, screening should be at the top of your "to-do" list.

Quick Facts for Patients:
• The Age Shift: Leading health experts now recommend screening start at 45 for average-risk adults.
• Zero Symptoms: Screening is for people who feel healthy. Waiting for symptoms often means waiting too long.
• Your Choice: From simple at-home kits to colonoscopies, you have options.

If you are 45 and haven't been screened, it’s time to talk to your doctor. Early detection saves lives.

Learn more at https://bit.ly/47Bl4p0



References:
1. US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238

2.Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458-479. doi:10.14309/ajg.0000000000001122

3.Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016-1030. doi:10.1038/ajg.2017.174

Only two tests meet the highest evidence standard for colorectal cancer screening:Colonoscopy and f***l immunochemical t...
03/25/2026

Only two tests meet the highest evidence standard for colorectal cancer screening:

Colonoscopy and f***l immunochemical testing (FIT).

According to the U.S. Multi-Society Task Force on Colorectal Cancer, these Tier 1 tests rise above flexible sigmoidoscopy, multitarget stool DNA tests, colon capsule endoscopy, and CT colonography due to their strong evidence base demonstrating their cost-effectiveness, accuracy, and ability to prevent colorectal cancer incidence and mortality. Annual FIT and colonoscopy every 10 years also result in similar life-years gained.

This Colorectal Cancer Awareness Month (and every month moving forward!), recommend the best to your patients. Recommend Tier 1 tests.

Small test. Big difference.

Learn more at https://bit.ly/4ljJ6Lb



References:
1.Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-1030.

2.Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021;116(3):458-479.

Colon cancer is currently the second leading cause of cancer deaths, yet it is also one of the most preventable through ...
03/20/2026

Colon cancer is currently the second leading cause of cancer deaths, yet it is also one of the most preventable through early detection.

Despite this, more than 4 in 10 adults who should be screened are not staying up to date with their tests.

Don't wait for symptoms to appear. Talk to your doctor today about which screening option is right for you. It is a simple conversation that could literally save your life.

Learn more at https://bit.ly/4rodV2I



Reference:
Colorectal cancer facts & figures 2023-2025. American Cancer Society. Accessed January 25, 2023. https://bit.ly/40UYfZJ

Address

510 Furnace Dock Road
Cortlandt Manor, NY
10567

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm

Telephone

+19147395400

Alerts

Be the first to know and let us send you an email when Polymedco, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share